Short-term metabolic and hemodynamic effects of ephedra and guarana combinations
- PMID: 15961987
- DOI: 10.1016/j.clpt.2005.01.023
Short-term metabolic and hemodynamic effects of ephedra and guarana combinations
Abstract
Objective: Serious adverse health events have been reported with the use of dietary supplements containing ephedra and guarana. We sought to determine whether repeated dosing and multi-ingredient formulations contribute to the adverse effects of these supplements.
Methods: In this study, 16 healthy adults (8 women) took 2 doses each of ephedra-guarana alone, Xenadrine RFA, a multicomponent dietary supplement containing 25 mg ephedra alkaloids and 200 mg caffeine, or placebo 5 hours apart in a randomized, double-blind, 3-arm crossover study.
Results: Peak plasma ephedrine levels averaged 130 to 140 ng/mL. Compared with placebo, Xenadrine and ephedra-guarana significantly increased heart rate (maximum increase, 9.4 +/- 8.6 beats/min; P = .002), blood pressure (maximum increase in systolic and diastolic pressure, 11.5 +/- 10.7 mm Hg and 7.3 +/- 7.4 mm Hg, respectively; P = .015), postprandial glucose concentration (maximum change, 41.0 +/- 18.8 mg/dL; P < .0001), and insulin concentration (maximum change, 41.2 +/- 47.8 microIU/mL; P = .005). Serum potassium concentrations were significantly decreased by both treatments. Hemodynamic and metabolic changes were observed after both the first and second doses. However, plasma free fatty acid concentrations increased after the first dose only. Xenadrine RFA produced higher increases in glucose concentration than ephedra-guarana, but no other pharmacodynamic differences between the treatments were found.
Conclusions: Consumption of 2 doses of ephedra and guarana supplements, per supplement label recommendations, results in persistent increases in heart rate and blood pressure and unfavorable actions on glucose and potassium homeostasis. Such effects could be detrimental in persons with hypertension, atherosclerosis, or glucose intolerance, conditions that are strongly associated with obesity.
Similar articles
-
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.JAMA. 2004 Jan 14;291(2):216-21. doi: 10.1001/jama.291.2.216. JAMA. 2004. PMID: 14722148 Clinical Trial.
-
Hemodynamic effects of ephedra-free weight-loss supplements in humans.Am J Med. 2005 Sep;118(9):998-1003. doi: 10.1016/j.amjmed.2005.02.034. Am J Med. 2005. PMID: 16164886 Clinical Trial.
-
Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.Clin Pharmacol Ther. 2004 Apr;75(4):259-73. doi: 10.1016/j.clpt.2003.11.375. Clin Pharmacol Ther. 2004. PMID: 15060505 Clinical Trial.
-
Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.Clin Ther. 2015 Feb 1;37(2):275-301. doi: 10.1016/j.clinthera.2014.08.012. Epub 2014 Sep 26. Clin Ther. 2015. PMID: 25262198 Review.
-
Psychiatric symptoms associated with ephedra use.Expert Opin Drug Saf. 2005 Sep;4(5):879-84. doi: 10.1517/14740338.4.5.879. Expert Opin Drug Saf. 2005. PMID: 16111450 Review.
Cited by
-
Comprehensive review of cardiovascular toxicity of drugs and related agents.Med Res Rev. 2018 Jul;38(4):1332-1403. doi: 10.1002/med.21476. Epub 2018 Jan 5. Med Res Rev. 2018. PMID: 29315692 Free PMC article. Review.
-
Cardiomyopathy Related to a Weight Loss Supplement: A Case Report and Review of Literature.J Investig Med High Impact Case Rep. 2017 Jun 2;5(2):2324709617711462. doi: 10.1177/2324709617711462. eCollection 2017 Apr-Jun. J Investig Med High Impact Case Rep. 2017. PMID: 28616440 Free PMC article.
-
The effects of a fat loss supplement on resting metabolic rate and hemodynamic variables in resistance trained males: a randomized, double-blind, placebo-controlled, cross-over trial.J Int Soc Sports Nutr. 2016 Apr 1;13:14. doi: 10.1186/s12970-016-0125-z. eCollection 2016. J Int Soc Sports Nutr. 2016. PMID: 27042166 Free PMC article. Clinical Trial.
-
The effects of a single-dose thermogenic supplement on resting metabolic rate and hemodynamic variables in healthy females--a randomized, double-blind, placebo-controlled, cross-over trial.J Int Soc Sports Nutr. 2016 Mar 31;13:13. doi: 10.1186/s12970-016-0123-1. eCollection 2016. J Int Soc Sports Nutr. 2016. PMID: 27034624 Free PMC article. Clinical Trial.
-
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety.Front Pharmacol. 2014 Jan 10;4:177. doi: 10.3389/fphar.2013.00177. eCollection 2014 Jan 10. Front Pharmacol. 2014. PMID: 24454289 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical